Melanoma Diagnostics Market: By Type of Condition, By Type of Test, Fiber Diffraction, Tissue Elastography, Thermal Imaging, Positron emission tomography, MRI Scan, CT-Scan, Sentinel Lymph Node Biopsy), By End User and Geography   

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Melanoma Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type of Condition (Superficial Spreading Melanoma, Lentigo Maligna Melanoma, Nodular Melanoma, Acral Lentiginous Melanoma), By Type of Test (Dermatoscopy, Optical Coherence Tomography, Multispectral Imaging, Non-invasive Genome Detection, Electrical impedance spectroscopy (EIS), Fiber Diffraction, Tissue Elastography, Thermal Imaging, Positron emission tomography (PET), MRI Scan, CT-Scan, Sentinel Lymph Node Biopsy), By End User (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) and Region   

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Melanoma Diagnostics Market size was valued at US$ 3.1 billion in 2023 and is poised to grow at a CAGR of 7% from 2024-2030. Melanoma is the more serious type of cancer that develops in cells of the skin called melanocytes that produce melanin. Melanoma not only affects the skin but it also affects the eyes and rarely, affects internal organs such as the intestine. The exact cause of melanoma is not clearly known, but the exposure of skin to UV radiation or tanning lamps and beds increases the risk of developing melanoma.

The Melanoma Diagnostics market is primarily driven by the increase in the number of people suffering from melanoma coupled with the advancements and approvals of new technologies for the diagnosis of melanoma. In addition, the growing number of developments, current pipeline tests and biomarkers and their expected approvals during the forecast period projected to boost the market over the forecast period. Furthermore, increase in government support and R&D activities to fight against cancer coupled with various initiatives by government and non-government organizations expected to bolster the market growth over the forecast period. However, high cost associated with the diagnosis process, regulatory constraints may hinder the growth of the market globally.

Melanoma Diagnostics Market Key Developments

  • In January 2014, Michelson diagnostics, UK based medical device company focused on multi beam optical coherence tomography technology and received award of ‚¬2.26 million Framework 7 grant to a consortium of seven partners, towards the cost of project targeting malignant with OCT imaging.

summary download arrow Download Free Sample

Melanoma Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7%

Largest Market

Europe

Fastest Growing Market

North-America

Melanoma Diagnostics Market Dynamics

The upsurge in the global melanoma prevalence rates and pipeline drugs for the treatment of melanoma is projected to boost the market at significant rates over the forecast period. According to World Health Organization (WHO), there is a continuous increase in the global prevalence of melanoma worldwide and estimated to be 132,000 melanoma skin cancers occur every year. Companies in the marketplace are focused on the development of new biomarker assays and tests for the diagnosis of melanoma. Furthermore, companies also focus on collaborations and acquisitions to develop new drug treatments and expand their portfolio in the market. For instance, in January 2018, Skyline Dx INKS entered into a joint development agreement with mayo clinic to develop diagnostic tests for melanoma

Melanoma Diagnostics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 3.1 billion

Market CAGR

7%

By Type of condition

  • Superficial Spreading Melanoma
  • Lentigo Maligna Melanoma
  • Nodular Melanoma
  • Acral Lentiginous Melanoma

By Type of Test

  • Dermatoscopy
  • Optical Coherence Tomography
  • Multispectral Imaging
  • Non-invasive Genome Detection
  • Electrical impedance spectroscopy (EIS)
  • Fiber Diffraction
  • Tissue Elastography
  • Thermal Imaging
  • Positron emission tomography (PET)
  • MRI Scan
  • CT-Scan
  • Sentinel Lymph Node Biopsy

By End User

  • Diagnostic Centers
  • Hospitals
  • Ambulatory Surgical Centers

Key Features of the Report

  • The melanoma diagnostics market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global melanoma diagnostics market size was valued at US$ 3.1 billion in 2023 and is projected to grow at a CAGR of 7% from 2024 to 2030.

Pfizer, Sanofi S.A, Novartis, Merck & Co., Inc, Becton, Dickinson & Co.

North America is the fastest-growing region for melanoma diagnostics market  

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Melanoma Diagnostics Market Introduction 
2.1.Global Melanoma Diagnostics Market  - Taxonomy
2.2.Global Melanoma Diagnostics Market  - Definitions
2.2.1.Type of condition
2.2.2.Type of Test
2.2.3.End User
2.2.4.Region
3. Global Melanoma Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Melanoma Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Melanoma Diagnostics Market  By Type of condition, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Superficial Spreading Melanoma
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Lentigo Maligna Melanoma
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Nodular Melanoma
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Acral Lentiginous Melanoma
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Melanoma Diagnostics Market  By Type of Test, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Dermatoscopy
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Optical Coherence Tomography
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Multispectral Imaging
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Non-invasive Genome Detection
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Electrical impedance spectroscopy (EIS)
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Fiber Diffraction
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Tissue Elastography
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Thermal Imaging
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
6.9. Positron emission tomography (PET)
6.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.9.3. Market Opportunity Analysis 
6.10. MRI Scan
6.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.10.3. Market Opportunity Analysis 
6.11. CT-Scan
6.11.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.11.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.11.3. Market Opportunity Analysis 
6.12. Sentinel Lymph Node Biopsy
6.12.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.12.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.12.3. Market Opportunity Analysis 
7. Global Melanoma Diagnostics Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Diagnostic Centers
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Hospitals
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Ambulatory Surgical Centers
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Melanoma Diagnostics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Melanoma Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type of condition Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Superficial Spreading Melanoma
9.1.2.Lentigo Maligna Melanoma
9.1.3.Nodular Melanoma
9.1.4.Acral Lentiginous Melanoma
9.2.  Type of Test Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Dermatoscopy
9.2.2.Optical Coherence Tomography
9.2.3.Multispectral Imaging
9.2.4.Non-invasive Genome Detection
9.2.5.Electrical impedance spectroscopy (EIS)
9.2.6.Fiber Diffraction
9.2.7.Tissue Elastography
9.2.8.Thermal Imaging
9.2.9.Positron emission tomography (PET)
9.2.10.MRI Scan
9.2.11.CT-Scan
9.2.12.Sentinel Lymph Node Biopsy
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Diagnostic Centers
9.3.2.Hospitals
9.3.3.Ambulatory Surgical Centers
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Melanoma Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type of condition Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Superficial Spreading Melanoma
10.1.2.Lentigo Maligna Melanoma
10.1.3.Nodular Melanoma
10.1.4.Acral Lentiginous Melanoma
10.2.  Type of Test Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Dermatoscopy
10.2.2.Optical Coherence Tomography
10.2.3.Multispectral Imaging
10.2.4.Non-invasive Genome Detection
10.2.5.Electrical impedance spectroscopy (EIS)
10.2.6.Fiber Diffraction
10.2.7.Tissue Elastography
10.2.8.Thermal Imaging
10.2.9.Positron emission tomography (PET)
10.2.10.MRI Scan
10.2.11.CT-Scan
10.2.12.Sentinel Lymph Node Biopsy
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Diagnostic Centers
10.3.2.Hospitals
10.3.3.Ambulatory Surgical Centers
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Melanoma Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type of condition Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Superficial Spreading Melanoma
11.1.2.Lentigo Maligna Melanoma
11.1.3.Nodular Melanoma
11.1.4.Acral Lentiginous Melanoma
11.2.  Type of Test Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Dermatoscopy
11.2.2.Optical Coherence Tomography
11.2.3.Multispectral Imaging
11.2.4.Non-invasive Genome Detection
11.2.5.Electrical impedance spectroscopy (EIS)
11.2.6.Fiber Diffraction
11.2.7.Tissue Elastography
11.2.8.Thermal Imaging
11.2.9.Positron emission tomography (PET)
11.2.10.MRI Scan
11.2.11.CT-Scan
11.2.12.Sentinel Lymph Node Biopsy
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Diagnostic Centers
11.3.2.Hospitals
11.3.3.Ambulatory Surgical Centers
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Melanoma Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type of condition Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Superficial Spreading Melanoma
12.1.2.Lentigo Maligna Melanoma
12.1.3.Nodular Melanoma
12.1.4.Acral Lentiginous Melanoma
12.2.  Type of Test Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Dermatoscopy
12.2.2.Optical Coherence Tomography
12.2.3.Multispectral Imaging
12.2.4.Non-invasive Genome Detection
12.2.5.Electrical impedance spectroscopy (EIS)
12.2.6.Fiber Diffraction
12.2.7.Tissue Elastography
12.2.8.Thermal Imaging
12.2.9.Positron emission tomography (PET)
12.2.10.MRI Scan
12.2.11.CT-Scan
12.2.12.Sentinel Lymph Node Biopsy
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Diagnostic Centers
12.3.2.Hospitals
12.3.3.Ambulatory Surgical Centers
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Melanoma Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type of condition Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Superficial Spreading Melanoma
13.1.2.Lentigo Maligna Melanoma
13.1.3.Nodular Melanoma
13.1.4.Acral Lentiginous Melanoma
13.2.  Type of Test Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Dermatoscopy
13.2.2.Optical Coherence Tomography
13.2.3.Multispectral Imaging
13.2.4.Non-invasive Genome Detection
13.2.5.Electrical impedance spectroscopy (EIS)
13.2.6.Fiber Diffraction
13.2.7.Tissue Elastography
13.2.8.Thermal Imaging
13.2.9.Positron emission tomography (PET)
13.2.10.MRI Scan
13.2.11.CT-Scan
13.2.12.Sentinel Lymph Node Biopsy
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Diagnostic Centers
13.3.2.Hospitals
13.3.3.Ambulatory Surgical Centers
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Abbott Laboratories (U.S)
14.2.2.Ariad Pharmaceuticals, Inc. (U.S)
14.2.3.Pfizer (U.S)
14.2.4.Sanofi S.A (France)
14.2.5.Novartis (Switzerland)
14.2.6.Merck & Co., Inc. (U.S)
14.2.7.Becton, Dickinson & Co. (U.S)
14.2.8.Eli Lilly and Co (U.S)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Abbott Laboratories
  • Ariad Pharmaceuticals, Inc.
  • Pfizer
  • Sanofi S.A
  • Novartis
  • Merck & Co., Inc.
  • Becton, Dickinson & Co.
  • Eli Lilly and Co
  • Siemens Healthcare Inc.
  • F. Hoffman-La Roche Ltd.
  • GlaxoSmithKline Plc., etc.
  • AstraZeneca plc
  • Bristol-Myers Squibb

Related Industry Reports

Optical Genome Mapping Market

Melanoma Treatment Market

Optical Imaging Market

Global Molecular Diagnostics Market